Works matching AU Meyer, Ralph M.


Results: 35
    1
    2
    3
    4
    5

    Yttrium 90 ibritumomab tiuxetan in lymphoma.

    Published in:
    Leukemia & Lymphoma, 2006, v. 47, n. 6, p. 967, doi. 10.1080/10428190600572582
    By:
    • Cheung, Matthew C.;
    • Haynes, Adam E.;
    • Stevens, Adrienne;
    • Meyer, Ralph M.;
    • Imrie, Kevin;
    • The members of the hematology disease site group of the cancer care Ontario program in evidence-based care
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial.

    Published in:
    Current Oncology, 2021, v. 28, n. 2, p. 1256, doi. 10.3390/curroncol28020119
    By:
    • Prica, Anca;
    • Hay, Annette E.;
    • Crump, Michael;
    • Mittmann, Nicole;
    • Shepherd, Lois E.;
    • Meyer, Ralph M.;
    • Imrie, Kevin I.;
    • Risebrough, Nancy;
    • Djurfeldt, Marina;
    • Chen, Bingshu E.;
    • Cheung, Matthew C.
    Publication type:
    Article
    12
    13
    14

    Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2319, doi. 10.1080/10428194.2017.1312379
    By:
    • Skamene, Tanya;
    • Crump, Michael;
    • Savage, Kerry J.;
    • Reiman, Tony;
    • Kuruvilla, John;
    • Good, David;
    • LeBrun, David;
    • Meyer, Ralph M.;
    • Sehn, Laurie H.;
    • Soulières, Denis;
    • Stakiw, Julie;
    • Laferriere, Nicole;
    • Luminari, Stefano;
    • Shepherd, Lois E.;
    • Djurfeldt, Marina;
    • Zhu, Liting;
    • Chen, Bingshu E.;
    • Hay, Annette E.
    Publication type:
    Article
    15

    Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 1, p. 64, doi. 10.1080/10428194.2016.1187274
    By:
    • Baetz, Tara;
    • Chen, Bingshu E.;
    • Couban, Stephen;
    • Tom Kouroukis, C.;
    • Buckstein, Rena;
    • Kuruvilla, John;
    • Howson-Jan, Kang;
    • Szwajcer, David;
    • Federico, Massimo;
    • Meyer, Ralph M.;
    • Djurfeldt, Marina S.;
    • Hay, Annette E.;
    • Shepherd, Lois;
    • Crump, Michael
    Publication type:
    Article
    16

    A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 2, p. 203, doi. 10.1111/j.1365-2141.2006.06405.x
    By:
    • Shustik, Chaim;
    • Belch, Andrew;
    • Robinson, Sue;
    • Rubin, Sheldon H.;
    • Dolan, Sean P.;
    • Kovacs, Michael J.;
    • Grewal, Kuljit S.;
    • Walde, David;
    • Barr, Robert;
    • Wilson, Jonathan;
    • Gill, Kulwant;
    • Vickars, Linda;
    • Rudinskas, Leona;
    • Sicheri, Dolores A.;
    • Wilson, Kenneth;
    • Djurfeldt, Marina;
    • Shepherdi, Lois E.;
    • Ding, Keyue;
    • Meyer, Ralph M.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10.

    Published in:
    British Journal of Haematology, 2015, v. 168, n. 4, p. 511, doi. 10.1111/bjh.13176
    By:
    • Kovacs, Michael J.;
    • Davies, Gwynivere A.;
    • Chapman, Judy‐Anne W.;
    • Bahlis, Nizar;
    • Voralia, Michael;
    • Roy, Jean;
    • Kouroukis, C. Tom;
    • Chen, Christine;
    • Belch, Andrew;
    • Reece, Donna;
    • Zhu, Liting;
    • Meyer, Ralph M.;
    • Shepherd, Lois;
    • Stewart, Keith A.
    Publication type:
    Article
    24

    Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC—Twenty-Three Randomized Trial.

    Published in:
    American Journal of Hospice & Palliative Medicine, 2018, v. 35, n. 4, p. 718, doi. 10.1177/1049909117733435
    By:
    • Chow, Selina;
    • Ding, Keyue;
    • Wan, Bo Angela;
    • Brundage, Michael;
    • Meyer, Ralph M.;
    • Nabid, Abdenour;
    • Chabot, Pierre;
    • Coulombe, Genevieve;
    • Ahmed, Shahida;
    • Kuk, Joda;
    • Dar, A. Rashid;
    • Mahmud, Aamer;
    • Fairchild, Alysa;
    • Wilson, Carolyn F.;
    • Wu, Jackson S. Y.;
    • Dennis, Kristopher;
    • DeAngelis, Carlo;
    • Wong, Rebecca K. S.;
    • Zhu, Liting;
    • Chow, Edward
    Publication type:
    Article
    25

    Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.

    Published in:
    2018
    By:
    • Raman, Srinivas;
    • Ding, Keyue;
    • Chow, Edward;
    • Meyer, Ralph M.;
    • van der Linden, Yvette M.;
    • Roos, Daniel;
    • Hartsell, William F.;
    • Hoskin, Peter;
    • Wu, Jackson S. Y.;
    • Nabid, Abdenour;
    • Haas, Rick;
    • Wiggenraad, Ruud;
    • Babington, Scott;
    • Demas, William F.;
    • Wilson, Carolyn F.;
    • Wong, Rebecca K. S.;
    • Zhu, Liting;
    • Brundage, Michael
    Publication type:
    journal article
    26

    Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.

    Published in:
    2016
    By:
    • Raman, Srinivas;
    • Ding, Keyue;
    • Chow, Edward;
    • Meyer, Ralph;
    • Nabid, Abdenour;
    • Chabot, Pierre;
    • Coulombe, Genevieve;
    • Ahmed, Shahida;
    • Kuk, Joda;
    • Dar, A.;
    • Mahmud, Aamer;
    • Fairchild, Alysa;
    • Wilson, Carolyn;
    • Wu, Jackson;
    • Dennis, Kristopher;
    • DeAngelis, Carlo;
    • Wong, Rebecca;
    • Zhu, Liting;
    • Brundage, Michael;
    • Meyer, Ralph M
    Publication type:
    journal article
    27
    28
    29

    Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv106
    By:
    • Cheung, Matthew C.;
    • Hay, Annette E.;
    • Crump, Michael;
    • Imrie, Kevin R.;
    • Song, Yuyao;
    • Hassan, Shazia;
    • Risebrough, Nancy;
    • Sussman, Jonathan;
    • Couban, Stephen;
    • MacDonald, David;
    • Kukreti, Vishal;
    • Kouroukis, C. Tom;
    • Baetz, Tara;
    • Szwajcer, David;
    • Desjardins, Pierre;
    • Shepherd, Lois;
    • Meyer, Ralph M.;
    • Le, Al;
    • Chen, Bingshu E.;
    • Mittmann, Nicole
    Publication type:
    Article
    30
    31
    32
    33
    34
    35